Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)


Journal article


Alexander R Lucas, Ralph D’Agostino Jr, Jennifer H Jordan, Kerryn W Reding, Nathaniel S O’Connell, Giselle C Melendez, Fadi N Salloum, Kathryn E Weaver, Glenn J Lesser, W Gregory Hundley
Cardio Oncology, vol. 5, American College of Cardiology Foundation Washington DC, 2023, pp. 412--414

Cite

Cite

APA   Click to copy
Lucas, A. R., D’Agostino Jr, R., Jordan, J. H., Reding, K. W., O’Connell, N. S., Melendez, G. C., … Hundley, W. G. (2023). Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213). Cardio Oncology, 5, 412–414.


Chicago/Turabian   Click to copy
Lucas, Alexander R, Ralph D’Agostino Jr, Jennifer H Jordan, Kerryn W Reding, Nathaniel S O’Connell, Giselle C Melendez, Fadi N Salloum, Kathryn E Weaver, Glenn J Lesser, and W Gregory Hundley. “Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213).” Cardio Oncology 5 (2023): 412–414.


MLA   Click to copy
Lucas, Alexander R., et al. “Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213).” Cardio Oncology, vol. 5, American College of Cardiology Foundation Washington DC, 2023, pp. 412–14.


BibTeX   Click to copy

@article{lucas2023a,
  title = {Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)},
  year = {2023},
  journal = {Cardio Oncology},
  pages = {412--414},
  publisher = {American College of Cardiology Foundation Washington DC},
  volume = {5},
  author = {Lucas, Alexander R and D’Agostino Jr, Ralph and Jordan, Jennifer H and Reding, Kerryn W and O’Connell, Nathaniel S and Melendez, Giselle C and Salloum, Fadi N and Weaver, Kathryn E and Lesser, Glenn J and Hundley, W Gregory}
}


Share

Tools
Translate to